blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3905977

EP3905977 - SYSTEMS FOR TISSUE TREATMENT [Right-click to bookmark this link]
Former [2021/45]SYSTEMS AND METHODS FOR TISSUE TREATMENT
[2022/39]
StatusNo opposition filed within time limit
Status updated on  24.11.2023
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  16.12.2022
FormerGrant of patent is intended
Status updated on  12.09.2022
FormerRequest for examination was made
Status updated on  08.10.2021
FormerThe international publication has been made
Status updated on  11.07.2020
Most recent event   Tooltip30.08.2024Lapse of the patent in a contracting state
New state(s): MC
published on 02.10.2024 [2024/40]
Applicant(s)For all designated states
Avava, Inc.
275 Second Avenue, 3rd Floor
Waltham, MA 02451 / US
[2023/13]
Former [2021/45]For all designated states
Avava, Inc.
185 Cambridge Street, Second Floor
Boston MA 02114 / US
Inventor(s)01 / DRESSER, Charles Holland
c/o AVAVA, Inc. 185 Cambridge Street, 2nd Floor
Boston, Massachusetts 02114 / US
02 / BHAWALKAR, Jayant
c/o AVAVA, Inc. 185 Cambridge Street, 2nd Floor
Boston, Massachusetts 02114 / US
03 / TING, Joseph
c/o AVAVA, Inc. 185 Cambridge Street, 2nd Floor
Boston, Massachusetts 02114 / US
 [2023/03]
Former [2021/45]01 / DRESSER, Charles Holland
Boston, Massachusetts 02114 / US
02 / BHAWALKAR, Jayant
Boston, Massachusetts 02114 / US
03 / TING, Joseph
Boston, Massachusetts 02114 / US
Representative(s)LKGLOBAL Lorenz & Kopf Patentanwalt Attorney at Law PartG mbB
Brienner Straße 11
80333 München / DE
[N/P]
Former [2021/45]LKGLOBAL Lorenz & Kopf PartG mbB Patentanwälte
Brienner Straße 11
80333 München / DE
Application number, filing date18945410.131.12.2018
[2021/45]
WO2018US68192
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020142083
Date:09.07.2020
Language:EN
[2020/28]
Type: A1 Application with search report 
No.:EP3905977
Date:10.11.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 09.07.2020 takes the place of the publication of the European patent application.
[2021/45]
Type: B1 Patent specification 
No.:EP3905977
Date:18.01.2023
Language:EN
[2023/03]
Search report(s)International search report - published on:US09.07.2020
(Supplementary) European search report - dispatched on:EP26.11.2021
ClassificationIPC:A61B18/02, A61B18/20, A61N5/067, // A61B18/00, A61B34/20
[2021/52]
CPC:
A61B18/203 (EP,IL,KR); A61B90/04 (KR); A61B2018/00023 (EP,IL,KR);
A61B2018/00458 (EP,IL); A61B2018/0047 (EP,IL); A61B2018/00476 (EP,IL);
A61B2018/00565 (EP,IL); A61B2018/00577 (EP,IL); A61B2018/00642 (EP,IL);
A61B2018/00672 (EP,IL); A61B2018/00678 (EP,IL); A61B2018/00708 (EP,IL);
A61B2018/00714 (EP,IL); A61B2018/00732 (EP,IL); A61B2018/00744 (EP,IL);
A61B2018/00761 (EP,IL); A61B2018/00821 (EP,IL); A61B2018/20353 (EP,IL,KR);
A61B2018/20553 (EP,IL,KR); A61B2018/205547 (KR); A61B2018/2253 (KR);
A61B2034/2048 (EP,IL); A61B2090/049 (KR) (-)
Former IPC [2021/45]A61B18/02, A61B18/20, A61N5/067
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/45]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:SYSTEME ZUR GEWEBEBEHANDLUNG[2022/39]
English:SYSTEMS FOR TISSUE TREATMENT[2022/39]
French:SYSTÈMES DE TRAITEMENT TISSULAIRE[2022/39]
Former [2021/45]SYSTEME UND VERFAHREN ZUR GEWEBEBEHANDLUNG
Former [2021/45]SYSTEMS AND METHODS FOR TISSUE TREATMENT
Former [2021/45]SYSTÈME ET PROCÉDÉS DE TRAITEMENT TISSULAIRE
Entry into regional phase23.07.2021National basic fee paid 
23.07.2021Search fee paid 
23.07.2021Designation fee(s) paid 
23.07.2021Examination fee paid 
Examination procedure23.07.2021Examination requested  [2021/45]
02.06.2022Amendment by applicant (claims and/or description)
13.09.2022Communication of intention to grant the patent
08.12.2022Fee for grant paid
08.12.2022Fee for publishing/printing paid
08.12.2022Receipt of the translation of the claim(s)
Opposition(s)19.10.2023No opposition filed within time limit [2023/52]
Fees paidRenewal fee
23.07.2021Renewal fee patent year 03
16.12.2021Renewal fee patent year 04
14.11.2022Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT18.01.2023
CZ18.01.2023
DK18.01.2023
EE18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
MC18.01.2023
RO18.01.2023
RS18.01.2023
SE18.01.2023
SI18.01.2023
SK18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
[2024/40]
Former [2024/11]AT18.01.2023
CZ18.01.2023
DK18.01.2023
EE18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
RO18.01.2023
RS18.01.2023
SE18.01.2023
SI18.01.2023
SK18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
Former [2023/50]AT18.01.2023
CZ18.01.2023
DK18.01.2023
EE18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
RO18.01.2023
RS18.01.2023
SE18.01.2023
SK18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
Former [2023/49]AT18.01.2023
CZ18.01.2023
DK18.01.2023
EE18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
RO18.01.2023
RS18.01.2023
SE18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
Former [2023/48]AT18.01.2023
DK18.01.2023
EE18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
RS18.01.2023
SE18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
Former [2023/46]AT18.01.2023
DK18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
RS18.01.2023
SE18.01.2023
SM18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
Former [2023/39]AT18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
RS18.01.2023
SE18.01.2023
NO18.04.2023
GR19.04.2023
IS18.05.2023
Former [2023/37]AT18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
RS18.01.2023
SE18.01.2023
NO18.04.2023
GR19.04.2023
Former [2023/36]AT18.01.2023
FI18.01.2023
HR18.01.2023
LT18.01.2023
LV18.01.2023
RS18.01.2023
SE18.01.2023
NO18.04.2023
Former [2023/35]AT18.01.2023
HR18.01.2023
LT18.01.2023
RS18.01.2023
NO18.04.2023
Former [2023/34]LT18.01.2023
RS18.01.2023
Former [2023/33]LT18.01.2023
Documents cited:Search[A]US2001007068  (OTA YASUO [JP], et al) [A] 1-11 * the whole document *;
 [A]US2012179227  (SCHOMACKER KEVIN [US], et al) [A] 1-11 * the whole document *;
 [A]US2013150841  (SCHOMACKER KEVIN T [US], et al) [A] 1-11 * the whole document *;
 [A]US2017304645  (SCHOMACKER KEVIN [US], et al) [A] 1-11* the whole document *
International search[YA]US2001007068  (OTA YASUO [JP], et al) [Y] 22, 24-38, 40, 41 * , para [0044], [0047]-[0058], [0057] * [A] 23, 39;
 [Y]US6436094  (REUTER ERIC M [US]) [Y] 31, 32* , col 5, In 51-62 *;
 [YA]US2013150841  (SCHOMACKER KEVIN T [US], et al) [Y] 22, 24-38, 40, 41 * , para [0017], [0031], [0034]-[0038], [0041], [0043]-[0045], [0060] * [A] 23, 39;
 [XY]US2016089202  (SCHOMACKER KEVIN [US], et al) [X] 16, 20, 21 * , para [0080], [0083]-[0084], [0089]-[0090], [0095]-[0096] * [Y] 1-15, 17-19;
 [Y]WO2018112261  (NANOSPECTRA BIOSCIENCES INC [US]) [Y] 10 * , para [0105], [0107] *;
 [Y]US2018177550  (ANDERSON RICHARD ROX [US], et al) [Y] 1-15, 17-19 * , para [0023], [0025], [0077], [0088], [0092], [0104], [0113], [0131] *
by applicantUS2001007068
 US2016199132
 US20180624388
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.